Drug Shortage Report for DIHYDROERGOTAMINE (DHE), 1MG/ML
Report ID | 239039 |
Drug Identification Number | 00027243 |
Brand name | DIHYDROERGOTAMINE (DHE), 1MG/ML |
Common or Proper name | DIHYDROERGOTAMINE MESYLATE INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | DIHYDROERGOTAMINE MESYLATE |
Strength(s) | 1MG |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 5 AMPOULES |
ATC code | N02CA |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-10-31 |
Actual start date | |
Estimated end date | 2025-02-10 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-10-01 |
Company comments | Inventory is available with October 31st, 2024 expiry. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-10-01 | French | Compare |
v1 | 2024-10-01 | English | Compare |
Showing 1 to 2 of 2